# Comparing the Effects of Insulin Glargine on Blood Glucose Between Needle-free Jet Injection and Insulin Pen

Study · id `cardio:ct-nct04074603` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04074603](<https://clinicaltrials.gov/study/NCT04074603>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04074603

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 150 participants.

## Technical summary

Registry record NCT04074603. Randomized; no masking; primary purpose treatment. Start 2019-09-01 (actual); primary completion 2020-12-31 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 150 participants (enrolled count; ClinicalTrials.gov record NCT04074603, source copy `cardio:ctgov-nct04074603-2022-10-27`, retrieved 2026-10-26)
- Started: 2019-09-01 (actual) (ClinicalTrials.gov record NCT04074603, source copy `cardio:ctgov-nct04074603-2022-10-27`, retrieved 2026-10-26)
- Primary completion: 2020-12-31 (actual) (ClinicalTrials.gov record NCT04074603, source copy `cardio:ctgov-nct04074603-2022-10-27`, retrieved 2026-10-26)
- Completion: 2021-12-31 (actual) (ClinicalTrials.gov record NCT04074603, source copy `cardio:ctgov-nct04074603-2022-10-27`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT04074603, source copy `cardio:ctgov-nct04074603-2022-10-27`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04074603-2022-10-27`, retrieved 2026-10-26)

## The registry's words

- Brief title: Comparing the Effects of Insulin Glargine on Blood Glucose Between Needle-free Jet Injection and Insulin Pen
- Condition: Type 2 Diabetes
- Intervention (Device): The needle-free jet injector
- Intervention (Device): Conventional insulin pen
- Lead sponsor: Jian-hua Ma
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)

## Provenance

Content hash: 7a508d47ffb2b744f2606b3de77396cfb586616e79355ea2df96f9f3734c0017
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
